273 related articles for article (PubMed ID: 29026098)
1. HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.
Säljö K; Barone A; Mölne J; Rydberg L; Teneberg S; Breimer ME
Sci Rep; 2017 Oct; 7(1):13072. PubMed ID: 29026098
[TBL] [Abstract][Full Text] [Related]
2. Sialyl-lactotetra, a novel cell surface marker of undifferentiated human pluripotent stem cells.
Barone A; Säljö K; Benktander J; Blomqvist M; Månsson JE; Johansson BR; Mölne J; Aspegren A; Björquist P; Breimer ME; Teneberg S
J Biol Chem; 2014 Jul; 289(27):18846-59. PubMed ID: 24841197
[TBL] [Abstract][Full Text] [Related]
3. Blood group ABO antigen expression in human embryonic stem cells and in differentiated hepatocyte- and cardiomyocyte-like cells.
Mölne J; Björquist P; Andersson K; Diswall M; Jeppsson A; Strokan V; Rydberg L; Breimer ME
Transplantation; 2008 Nov; 86(10):1407-13. PubMed ID: 19034011
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the glycosphingolipids of human-induced pluripotent stem cells and human embryonic stem cells.
Säljö K; Barone A; Vizlin-Hodzic D; Johansson BR; Breimer ME; Funa K; Teneberg S
Glycobiology; 2017 Apr; 27(4):291-305. PubMed ID: 27932383
[TBL] [Abstract][Full Text] [Related]
5. HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications.
Karabekian Z; Ding H; Stybayeva G; Ivanova I; Muselimyan N; Haque A; Toma I; Posnack NG; Revzin A; Leitenberg D; Laflamme MA; Sarvazyan N
Tissue Eng Part A; 2015 Oct; 21(19-20):2559-71. PubMed ID: 26218149
[TBL] [Abstract][Full Text] [Related]
6. Characteristic expression of major histocompatibility complex and immune privilege genes in human pluripotent stem cells and their derivatives.
Chen HF; Yu CY; Chen MJ; Chou SH; Chiang MS; Chou WH; Ko BS; Huang HP; Kuo HC; Ho HN
Cell Transplant; 2015; 24(5):845-64. PubMed ID: 24144439
[TBL] [Abstract][Full Text] [Related]
7. Recent Trends in Research with Human Pluripotent Stem Cells: Impact of Research and Use of Cell Lines in Experimental Research and Clinical Trials.
Guhr A; Kobold S; Seltmann S; Seiler Wulczyn AEM; Kurtz A; Löser P
Stem Cell Reports; 2018 Aug; 11(2):485-496. PubMed ID: 30033087
[TBL] [Abstract][Full Text] [Related]
8. Haematopoietic developmental potential of human pluripotent stem cell lines.
Tesařová L; Simara P; Stejskal S; Koutná I
Folia Biol (Praha); 2014; 60 Suppl 1():90-4. PubMed ID: 25369348
[TBL] [Abstract][Full Text] [Related]
9. Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.
Polanco JC; Ho MS; Wang B; Zhou Q; Wolvetang E; Mason E; Wells CA; Kolle G; Grimmond SM; Bertoncello I; O'Brien C; Laslett AL
Stem Cells; 2013 Aug; 31(8):1498-510. PubMed ID: 23728894
[TBL] [Abstract][Full Text] [Related]
10. HLA engineering of human pluripotent stem cells.
Riolobos L; Hirata RK; Turtle CJ; Wang PR; Gornalusse GG; Zavajlevski M; Riddell SR; Russell DW
Mol Ther; 2013 Jun; 21(6):1232-41. PubMed ID: 23629003
[TBL] [Abstract][Full Text] [Related]
11. High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry.
Bhattacharya S; Burridge PW; Kropp EM; Chuppa SL; Kwok WM; Wu JC; Boheler KR; Gundry RL
J Vis Exp; 2014 Sep; (91):52010. PubMed ID: 25286293
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
Meng G; Liu S; Rancourt DE
Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
[TBL] [Abstract][Full Text] [Related]
13. Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem cells and their epidermal derivatives.
Zhao L; Teklemariam T; Hantash BM
Stem Cell Res; 2014 Sep; 13(2):342-54. PubMed ID: 25218797
[TBL] [Abstract][Full Text] [Related]
14. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
[TBL] [Abstract][Full Text] [Related]
15. Capturing the ephemeral human pluripotent state.
Ávila-González D; García-López G; García-Castro IL; Flores-Herrera H; Molina-Hernández A; Portillo W; Díaz NF
Dev Dyn; 2016 Jul; 245(7):762-73. PubMed ID: 27004967
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells.
Yanagihara K; Liu Y; Kanie K; Takayama K; Kokunugi M; Hirata M; Fukuda T; Suga M; Nikawa H; Mizuguchi H; Kato R; Furue MK
Stem Cells Dev; 2016 Dec; 25(24):1884-1897. PubMed ID: 27733097
[TBL] [Abstract][Full Text] [Related]
17. Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces.
Venable A; Mitalipova M; Lyons I; Jones K; Shin S; Pierce M; Stice S
BMC Dev Biol; 2005 Jul; 5():15. PubMed ID: 16033656
[TBL] [Abstract][Full Text] [Related]
18. Efficient differentiation of human pluripotent stem cells to endothelial progenitors via small-molecule activation of WNT signaling.
Lian X; Bao X; Al-Ahmad A; Liu J; Wu Y; Dong W; Dunn KK; Shusta EV; Palecek SP
Stem Cell Reports; 2014 Nov; 3(5):804-16. PubMed ID: 25418725
[TBL] [Abstract][Full Text] [Related]
19. Early Development of Definitive Erythroblasts from Human Pluripotent Stem Cells Defined by Expression of Glycophorin A/CD235a, CD34, and CD36.
Mao B; Huang S; Lu X; Sun W; Zhou Y; Pan X; Yu J; Lai M; Chen B; Zhou Q; Mao S; Bian G; Zhou J; Nakahata T; Ma F
Stem Cell Reports; 2016 Nov; 7(5):869-883. PubMed ID: 27720903
[TBL] [Abstract][Full Text] [Related]
20. The safety of human pluripotent stem cells in clinical treatment.
Simonson OE; Domogatskaya A; Volchkov P; Rodin S
Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
